Sphingolipid profiling as a biomarker of type 2 diabetes risk: evidence from the MIDUS and PREDIMED studies
Author: L Berkowitz, C Razquin, C Salazar, F Biancardi et al.
Year Published: 2024
Media Outlet: Cardiovascular Diabetology
Open Access? No
Matrix:
Biological Themes:
Product(s):
Cited in over 3,000 publications, we help scientists and manufacturers gain greater insight into their studies through metabolomics.
GET STARTED
Talk with an expert
Request a quote, get detailed information on sample types, or learn how metabolomics can accelerate your research. Find our contact details are here.
Find us on:
